One-year survival after home-based pulmonary rehabilitation: a cohort study of 3,754 individuals with chronic respiratory diseases.

Authors:

Abstract
Aim. Although the effectiveness of home-based pulmonary rehabilitation (PR) has been reported in several chronic respiratory diseases, data on post-PR survival and associated factors remain limited, especially beyond COPD. The study aimed to assess one-year survival and its association with post-PR changes in clinical outcomes. Methods. This retrospective pre-post study used prospectively collected data from January 2010 to May 2025. Participants performed an 8-week home-based PR programme with face-to-face supervised sessions. Quality of life (CAT), dyspnea (mMRC), exercise tolerance (6-min stepper test, 6MST), and anxiety/depression (HADS) were assessed before and after PR. One-year survival was analysed using Kaplan Meir curves and Cox regression models. Results. Overall, 3,754 participants were included: 1,881 (50%) COPD, 768 (20%) ILD, and 379 (10%) asthma. One-year survival was 88% overall and 89%, 74% and 97% in COPD, ILD and asthma, respectively. Non-survivors were older, more often male and smokers, more frequently oxygen-dependent, and had lower body mass index, greater airflow obstruction, worse dyspnoea and quality of life, higher physical frailty, and reduced exercise capacity than survivors (all p<0.01). Post-PR changes in outcomes were independently associated with one-year survival (CAT HR 1.4, 95% CI 1.1–1.7; mMRC HR 2.0, 95% CI 1.6–2.4; HADS-D HR 1.4, 95% CI 1.2–1.6; 6MST HR 0.6, 95% CI 0.5–0.8; all p<0.005). Conclusion. In a large real-world cohort, one-year mortality after PR was 12% overall, highest in ILD (26%), as expected given disease progression. Changes in quality of life, dyspnea, depressive symptoms and exercise capacity after PR were independently associated with survival highlighting their potential prognostic value beyond the underlying disease.